<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Obsessive-compulsive disorder in children and adolescents: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Rosenberg, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Brent, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Michael Friedman, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 28, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H86799332">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obsessive-compulsive disorder (OCD) is a severe, prevalent and most often chronically debilitating disorder characterized by repetitive, ritualistic, and distressing thoughts, ideas, and behaviors over which a person typically has very little if any control.
        </p>
        <p>
         Research suggests approximately 50 percent of all cases have their onset in childhood and adolescence [
         <a href="#rid1">
          1,2
         </a>
         ]. Obsessions and compulsions in children are more likely to change/evolve as well as wax and wane, compared to the course of the disorder in adults.
        </p>
        <p>
         This topic reviews the epidemiology, pathogenesis, clinical manifestations, course, assessment and diagnosis of OCD in children and adolescents. The treatment of OCD in children and adolescents is discussed separately. The epidemiology, pathogenesis, clinical manifestations, course, assessment, diagnosis, and treatment of OCD in adults are also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/90748.html" rel="external">
          "Obsessive-compulsive disorder in children and adolescents: Treatment overview"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14629.html" rel="external">
          "Management of obsessive-compulsive disorder in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/498.html" rel="external">
          "Obsessive-compulsive disorder in adults: Epidemiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14636.html" rel="external">
          "Obsessive-compulsive disorder in adults: Psychotherapy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H86799339">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obsessive-compulsive disorder (OCD) affects more than three million people in the United States. Estimates of the disorder’s United States lifetime prevalence in both pediatric and adult populations have ranged from 1 to 3 percent [
         <a href="#rid3">
          3-5
         </a>
         ]. Research suggests that approximately 50 percent of all cases have their onset in childhood and adolescence [
         <a href="#rid1">
          1,2
         </a>
         ]. A United States epidemiologic study of a nationally representative sample reported that 21 percent of OCD cases had onset by age 10 years [
         <a href="#rid3">
          3
         </a>
         ], with a mean age of onset for pediatric OCD between 9 and 11 years in boys and 11 and 13 years in girls [
         <a href="#rid6">
          6
         </a>
         ]. Pediatric OCD appears to be more common in males than in females, in contrast to adults where the male-female ratio of OCD is approximately 1:1 [
         <a href="#rid7">
          7,8
         </a>
         ].
        </p>
        <p>
         A 1999 nationwide epidemiologic study of 10,438 5 to 15 year olds in the United Kingdom estimated a weighted overall prevalence of OCD at 0.25 percent (95% CI 0.14-0.35) [
         <a href="#rid9">
          9
         </a>
         ]. The children with OCD were more likely to be from lower socio-economic class and of lower intelligence compared to normal controls.
        </p>
        <p class="headingAnchor" id="H269256670">
         <span class="h2">
          Comorbidities
         </span>
         <span class="headingEndMark">
          —
         </span>
         More than half of pediatric patients with OCD have been found to have at least one comorbid psychiatric disorder [
         <a href="#rid10">
          10,11
         </a>
         ]. In a review of 11 epidemiological studies, children and/or adolescents with OCD have been found to have higher rates of co-occurring mental disorders compared to subjects without OCD [
         <a href="#rid1">
          1,8,12-18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Any psychiatric disorder, 63 to 97 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mood disorder, 13 to 70 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anxiety disorder, 13 to 70 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Disruptive behavior disorder, 3 to 57 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tic disorder/Tourette syndrome, 13 to 26 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Speech/developmental disorders, 13 to 27 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enuresis, 7 to 37 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pervasive developmental disorder, 3 to 7 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eating disorders, particularly in adolescents [
         <a href="#rid19">
          19,20
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         Co-occurring mood disorders and psychosis have increased prevalence in adolescents with OCD; co-occurring ADHD and non-OCD anxiety disorders have been found to occur at higher rates in children with an early age of onset of OCD [
         <a href="#rid21">
          21
         </a>
         ]. Separation anxiety disorder in some cases is a precursor to OCD onset in childhood.
        </p>
        <p class="headingAnchor" id="H86799346">
         <span class="h1">
          PATHOGENESIS
         </span>
        </p>
        <p class="headingAnchor" id="H86799353">
         <span class="h2">
          Etiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         The etiology of obsessive-compulsive disorder (OCD) is unknown; however, research suggests that multiple genetic risk factors lead to changes in cellular function or altered neurotransmitter signaling. These molecular and cellular changes perturb fronto-striatal-thalamic circuitry (FSTC), resulting in OCD.
        </p>
        <p class="headingAnchor" id="H86799360">
         <span class="h3">
          Genetic studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Twin and family studies provide compelling evidence that genetic factors are critically involved in the transmission and expression of OCD. Two controlled family studies of pediatric patients with OCD found the lifetime prevalence of OCD to be significantly higher in familial cases compared with control relatives [
         <a href="#rid22">
          22,23
         </a>
         ]. Family studies of pediatric OCD patients demonstrate that pediatric patients usually have a more familial form of the disorder that may be etiologically more homogeneous or more strongly associated with genes of major effect [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
         Segregation analyses provide compelling data that a major gene is important in transmitting OCD. A major susceptibility locus in a proportion of families with OCD was identified in five complex segregation analyses [
         <a href="#rid25">
          25-28
         </a>
         ]. A large segregation analysis of OCD supported an autosomal dominant or co-dominant model, and rejected a recessive model [
         <a href="#rid27">
          27
         </a>
         ]. The only segregation analysis of families that examined only pediatric OCD patients provided evidence for a major gene in families with OCD when age at onset was incorporated into the model [
         <a href="#rid26">
          26
         </a>
         ]. When simple Mendelian models were compared, the dominant model provided a better fit to the data than the other Mendelian models.
        </p>
        <p>
         A genome-wide linkage analysis of OCD in seven families of pediatric OCD patients identified a region on chromosome 9 with suggestive evidence for linkage. The glutamate transporter
         <em>
          SLC1A1
         </em>
         on chromosome 9 was implicated as a positional candidate gene for pediatric OCD by two research groups working independently [
         <a href="#rid29">
          29,30
         </a>
         ]. Family-based association studies also implicated the 9p24 region in OCD by identifying two microsatellite markers (D9S288 and GATA62F03) flanking the
         <em>
          SLC1A1.
         </em>
         Studies by other research teams have had findings implicating the glutamate transporter gene (
         <em>
          SLC1A1
         </em>
         ) [
         <a href="#rid6">
          6,31,32
         </a>
         ] and the glutamate receptor gene (
         <em>
          GRIN2B
         </em>
         ) [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H86799368">
         <span class="h3">
          Possible autoimmune subtype
         </span>
         <span class="headingEndMark">
          —
         </span>
         Immune responsivity to infections with group A beta-hemolytic streptococcus (GABHS) is believed to result in basal ganglia inflammation and resultant OCD, tic and/or ADHD symptoms [
         <a href="#rid34">
          34
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/6031.html" rel="external">
          "PANDAS: Pediatric autoimmune neuropsychiatric disorder associated with group A streptococci"
         </a>
         ). Immune-related dysregulation may also play a role in the pathophysiology of pediatric patients with OCD without a pediatric acute-onset neuropsychiatric syndrome diagnosis [
         <a href="#rid35">
          35-37
         </a>
         ].
        </p>
        <p>
         Increases in psychological stress lead to the upregulation and proliferation of “immature” circulating monocytes, which can enter the brain and have an enhanced capacity to release proinflammatory cytokines [
         <a href="#rid38">
          38
         </a>
         ]. These proinflammatory cytokines act to propagate the neuroinflammatory response and may also affect brain function and the metabolism and availability of different neurotransmitters [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
         An analysis of monocyte composition in whole blood comparing the percentage of total monocytes, proinflammatory CD16+ monocytes, and monocyte subsets (ie, classical [CD16-], intermediate [low-expressing, CD16+], and nonclassical [high-expressing, CD16+] subsets) in a sample of 102 OCD patients versus 47 control participants found significantly higher percentages of total monocytes, proinflammatory CD16+ monocytes, and of CD16+ expressing intermediate and nonclassical monocyte subsets in OCD versus control participants [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
         A follow-up analysis exploring the functionality of monocytes via the production of proinflammatory cytokines was conducted by exposing a fixed number of monocytes that was identical for each sample to lipopolysaccharide (LPS) to stimulate an immune response. Although the number of monocytes between groups was the same, higher levels of granulocyte-macrophage colony stimulating factor, interleukins 6, 8, and 1 beta, and tumor necrosis factor alpha were found in OCD participants versus healthy controls after exposure to LPS [
         <a href="#rid35">
          35
         </a>
         ]. No differences were observed in basal levels of monocyte activity and cytokine concentrations between OCD participants and controls in samples not exposed to LPS, suggesting an abnormal immune response in OCD participants that can become hyper-activated in response to immune triggers, such as psychological stress.
        </p>
        <p class="headingAnchor" id="H86799376">
         <span class="h3">
          Perinatal complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is some evidence to suggest that perinatal events are associated with a higher risk of OCD later in life. Perinatal trauma is significantly higher in tic-related OCD, which is more common in males. Higher rates of perinatal trauma have been reported in males with early onset OCD [
         <a href="#rid40">
          40
         </a>
         ]. Drug exposure in utero
         <em>
         </em>
         has been found to predict increased severity of tic-related OCD [
         <a href="#rid41">
          41
         </a>
         ]. Pediatric OCD patients with comorbid Tourette syndrome have been shown to be approximately five times more likely to have been exposed to alcohol, nicotine, and caffeine in utero and approximately eight times more likely to have been delivered by forceps [
         <a href="#rid42">
          42
         </a>
         ]. Pediatric OCD patients may also be more likely to have mothers who became ill during pregnancy necessitating medical intervention [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H111061048">
         <span class="h2">
          Neuroimaging
         </span>
        </p>
        <p class="headingAnchor" id="H86799420">
         <span class="h3">
          Structural
         </span>
         <span class="headingEndMark">
          —
         </span>
         Regions of the cortico-striatal-thalamic circuits have been implicated in the pathogenesis of OCD. Reduced striatal gray matter, which was most pronounced in patients with predominant checking and/or aggressive obsessions and compulsions but not in patients with other obsessions and compulsions, eg, contamination, washing, etc. was reported in pediatric OCD patients versus healthy controls [
         <a href="#rid7">
          7,44,45
         </a>
         ]. Increased anterior cingulate cortex gray matter (primarily in young patients) and orbital frontal cortex gray matter has been observed in pediatric OCD [
         <a href="#rid45">
          45-47
         </a>
         ]. Psychotropic-naïve pediatric patients with OCD had larger thalamic volumes when compared with age and sex-matched controls [
         <a href="#rid48">
          48,49
         </a>
         ]. Left amygdala-right amygdala volume ratios were increased in medication-naïve pediatric patients with OCD. Increased corpus callosum area in pediatric OCD patients versus age- and sex-matched healthy pediatric controls [
         <a href="#rid7">
          7
         </a>
         ] as well as increased right but not left orbital frontal white matter has been observed in pediatric OCD [
         <a href="#rid50">
          50
         </a>
         ]. Limbic-hypothalamic-pituitary-adrenal (LHPA) axis abnormalities have also been reported in OCD [
         <a href="#rid51">
          51-55
         </a>
         ]. Using volumetric MRI, reduction in pituitary volume, primarily in males not females, has been reported in pediatric OCD patients versus healthy pediatric controls [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         White matter alterations have been observed in pediatric OCD patients. Diffusion tensor imaging has shown increased fractional anisotropy, a potential measure of white matter fiber density, axonal diameter, and myelination in several white matter tracts including the corpus callosum (splenium and genu, and splenium respectively), the cingulum, and the inferior fronto-occipital fasciculus (right and left respectively) versus healthy pediatric controls [
         <a href="#rid57">
          57,58
         </a>
         ]. In a related study, fractional anisotropy found increases in several white matter tracts, including the corpus callosum (anterior corpus callosum and splenium), anterior cingulum bundle, and the internal capsule [
         <a href="#rid59">
          59
         </a>
         ]. All three studies reported a positive correlation between increased symptom severity and increased fractional anisotropy in either the splenium [
         <a href="#rid57">
          57,58
         </a>
         ] or the anterior cingulum bundle [
         <a href="#rid59">
          59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H86799476">
         <span class="h3">
          Functional
         </span>
         <span class="headingEndMark">
          —
         </span>
         Functional neuroimaging studies in adults with OCD have consistently implicated increased caudate and orbital frontal activity in OCD [
         <a href="#rid33">
          33,60-64
         </a>
         ]. Using functional magnetic resonance imaging (fMRI), a study reported developmental alterations of fronto-striatal-thalamic connections in OCD [
         <a href="#rid65">
          65
         </a>
         ]. Using fMRI to examine brain network interactions during a working memory task found hyperactivation profiles in dorsal prefrontal cortex, parietal lobe, and dorsal anterior cingulate cortex, but not in the striatum or thalamus, in pediatric patients with OCD [
         <a href="#rid66">
          66
         </a>
         ]. Increased dorsal anterior cingulate cortex modulation of cortical, striatal, and thalamic targets was observed, which remained consistent regardless of task difficulty.
        </p>
        <p class="headingAnchor" id="H86799491">
         <span class="h2">
          Neurochemistry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serotonin and key metabolites (N-acetyl-aspartate, choline, creatine/phosphocreatine, and glutamate) have been implicated in the neurochemistry of OCD [
         <a href="#rid67">
          67-75
         </a>
         ]. Reduced left and right medial thalamus N-acetyl-aspartate was reported in psychotropic-naïve pediatric OCD patients versus controls with reduced left medial thalamic N-acetyl-aspartate levels correlating inversely with increased OCD symptom severity [
         <a href="#rid76">
          76
         </a>
         ]. Psychotropic-naïve pediatric patients with OCD had significantly larger left and right medial thalamic choline levels compared with both healthy pediatric controls and psychotropic-naïve pediatric MDD patients who did not differ. Increased left and right medial thalamic creatine/phosphocreatine as well as increased left caudate creatine/phosphocreatine has been reported in psychotropic-naïve pediatric OCD patients compared with healthy pediatric controls [
         <a href="#rid69">
          69,71
         </a>
         ]. Reduced anterior cingulate glutamatergic concentrations and increased left caudate glutamatergic concentrations were found in psychotropic-naïve pediatric OCD patients compared with healthy pediatric controls [
         <a href="#rid69">
          69,74
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H49086758">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The characteristic symptoms of obsessive-compulsive disorder (OCD) are obsessions and/or compulsions that are time-consuming, cause clinically significant distress or impair functioning. Obsessions are repetitive and persistent thoughts, images, or urges.
        </p>
        <p>
         Obsessions are not pleasurable or experienced as voluntary. They are intrusive, unwanted, and cause marked distress or anxiety in most individuals. A person suffering from OCD attempts to ignore, avoid, or suppress obsessions, or may try to neutralize them with another thought or action (eg, performing a compulsion).
        </p>
        <p>
         Compulsions (or rituals) are repetitive behaviors (eg, washing, checking) or mental acts (eg, counting, repeating words silently) that may be performed in response to an obsession or according to rules that may be applied rigidly. Compulsions are not rationally connected to the feared event, or are clearly excessive.
        </p>
        <p>
         Although there is demonstrated continuity in the presentation of OCD in children and adults, the nature of obsessions and compulsions differ between youths and adults [
         <a href="#rid77">
          77
         </a>
         ]. In adults the male:female ratio of OCD is approximately 1:1, while pediatric OCD is more common in males than in females [
         <a href="#rid7">
          7
         </a>
         ]. Boys typically have an earlier age of onset (7 to 9 years) of OCD than girls (11 to 13 years), although it can occur earlier in both genders.
        </p>
        <p>
         Detecting obsessions can be more difficult in children with OCD compared to adults with the disorder. While compulsions can usually be observed, very young children may be unable to describe obsessive thoughts verbally or describe their aim in carrying out a compulsive action. Insight into the excessiveness or absurdity of the symptoms is characteristic in adults, but can be more difficult to identify particularly in younger children with OCD [
         <a href="#rid78">
          78
         </a>
         ].
        </p>
        <p>
         Developmental considerations should be considered when examining a child’s expression of obsessions and compulsions. Children with OCD are more likely than adults with OCD to present with compulsions without obvious obsessive symptoms [
         <a href="#rid6">
          6
         </a>
         ]. Obsessions and compulsions in children are more likely to change/evolve as well as wax and wane. Religious and sexual obsessions appear to be more common in adolescents than in children, while hoarding is seen more often in preadolescent children than in adolescents with OCD [
         <a href="#rid79">
          79-81
         </a>
         ].
        </p>
        <p>
         Families of pediatric patients with OCD may have high levels of anxiety. Associated anxiety in the child, parents and/or siblings can serve as a vicious cycle and exacerbate the child’s condition.
        </p>
        <p>
         In contrast to OCD in adults, OCD in children does not appear to increase the risk of suicide. Depression commonly co-occurs with OCD, however, and its presence is associated with an increased risk of suicide.
        </p>
        <p class="headingAnchor" id="H86799541">
         <span class="h1">
          COURSE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obsessive-compulsive disorder (OCD) that begins in childhood often persists into adulthood, frequently with a waxing and waning course. A meta-analysis of 521 children/adolescents with OCD in 22 longitudinal studies found that, in 40 percent of cases, full OCD persisted over the period subjects were followed (range = 1 to 15.6 years); in 60 percent of cases either full OCD or subthreshold OCD symptoms persisted [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
         The meta-analysis also found that earlier age of onset of OCD, increased duration of illness, and inpatient OCD treatment were associated with greater persistence of the disorder [
         <a href="#rid82">
          82
         </a>
         ]. The prognosis for pediatric OCD appears to be better than the prognosis for adult onset OCD [
         <a href="#rid83">
          83-85
         </a>
         ].
        </p>
        <p>
         Childhood OCD, in the absence of adequate treatment, is a serious and disabling disorder with a chronic but fluctuating course for the majority of patients [
         <a href="#rid86">
          86
         </a>
         ]. Symptoms may get somewhat better for months or even years, only to get worse again before returning to a lower level of severity [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         OCD in childhood can lead to impairment in long-term functioning, including problems with separation-individuation from parents and occupational achievement as adults [
         <a href="#rid82">
          82
         </a>
         ]. In a retrospective cohort study of 17 children with OCD (mean age of onset 9.6 years), 10 received a follow up assessment, which found that 7 of 10 still suffered OCD symptoms [
         <a href="#rid88">
          88
         </a>
         ]. Of seven subjects who were over 16 years, all seven were employed; two reported difficulty keeping a job.
        </p>
        <p class="headingAnchor" id="H86799548">
         <span class="h1">
          ASSESSMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         In conducting a psychiatric assessment for possible obsessive-compulsive disorder (OCD), the child and his or her parents should be asked about the presence or absence of each characteristic of OCD described in DSM-5 diagnostic criteria for the disorder. Assessment of these symptoms and behaviors over the child’s lifetime is particularly important in OCD, because obsessions and compulsions can wax and wane and change during the child’s developmental maturation. (See
         <a class="local">
          'Diagnosis'
         </a>
         below.)
        </p>
        <p>
         All patients should undergo a medical history and physical examination as part of a diagnostic assessment. Neurologic examination should assess for signs or symptoms indicating possible deficits or injury in brain regions implicated in OCD (eg, basal ganglia, frontal cortex, thalamus) and rule out other medical/neurologic conditions as a cause.
        </p>
        <p>
         Inquiries about repeated streptococcal infections, rheumatic fever, or Sydenham chorea are important, particularly if they coincide with onset/exacerbation of obsessive and compulsive symptoms, because group A beta hemolytic streptococcal infections have been associated with OCD in some children. Assessment, diagnosis, and treatment of these conditions are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3177.html" rel="external">
          "Acute rheumatic fever: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6228.html" rel="external">
          "Sydenham chorea"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5971.html" rel="external">
          "Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         In addition to the primary disorder, the child should be examined for co-occurring psychiatric disorders, particularly those that occur at an increased rate in OCD. (See
         <a class="local">
          'Comorbidities'
         </a>
         above.)
        </p>
        <p>
         The patient’s family history should be reviewed for OCD given genetic studies showing that a positive family history is associated with an elevated risk of the disorder in children. (See
         <a class="local">
          'Genetic studies'
         </a>
         above.)
        </p>
        <p>
         There are currently no genetic or neuropsychological tests or brain imaging findings with diagnostic or prognostic utility in OCD.
        </p>
        <p class="headingAnchor" id="H49086421">
         <span class="h2">
          Rating scales
         </span>
         <span class="headingEndMark">
          —
         </span>
         Valid and reliable scales can be used to identify symptoms and behaviors characteristic in OCD, and to monitor changes in the severity of obsessions and compulsions over time. The best studied, standardized scale is the Children’s Yale-Brown-Obsessive-Compulsive Scale (CY-BOCS) [
         <a href="#rid89">
          89
         </a>
         ]. This is a clinician rated scale; the clinician administering the scale should receive training from a mental health clinician experienced in the assessment of childhood OCD.
        </p>
        <p>
         While the CY-BOCS remains the most commonly used clinician rating scale, the use of brief screening questionnaires, such as the Obsessive-Compulsive Inventory – Child Version [
         <a href="#rid90">
          90,91
         </a>
         ], the OCD subscales of the Child Behavior Checklist (CBCL-OCS) [
         <a href="#rid92">
          92
         </a>
         ] and the Revised Children’s Anxiety and Depression Scale (RCADS) [
         <a href="#rid93">
          93
         </a>
         ], may also be useful for identifying OCD symptoms during an initial assessment [
         <a href="#rid94">
          94
         </a>
         ]. These screening tools can be administered quickly and inexpensively and without the need for additional clinician training. Both the CBCL-OCS and RCADS are also offered as parent and youth self-report versions, which can help more accurately identify both internalizing and externalizing OCD symptoms, that otherwise may be reported inaccurately, or may not be reported at all [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H49086543">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnosing pediatric obsessive-compulsive disorder (OCD) can be difficult. Intrusive thoughts, doubts, or images are almost universal in the general population and their content can be indistinguishable from clinical obsessions [
         <a href="#rid96">
          96
         </a>
         ]. Such intrusions occur, by definition, outside the volition of the person experiencing them and tend to interrupt other mental activity because they are inconsistent with the person's usual value system [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H476130752">
         <span class="h2">
          DSM-5 criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of OCD is based on DSM-5 diagnostic criteria [
         <a href="#rid98">
          98
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A. Presence of obsessions, compulsions, or both:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Obsessions as defined by:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         1. Recurrent and persistent thoughts, urges, or images that are experienced, at some time during the disturbance, as intrusive and unwanted, and that in most individuals cause marked anxiety or distress.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         2. The individual attempts to ignore or suppress such thoughts, urges, or images, or to neutralize them with some other thought or action (ie, by performing a compulsion).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Compulsions as defined by:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         1. Repetitive behaviors (eg, hand washing, ordering, checking) or mental acts (eg, praying, counting, repeating words silently) that the individual feels driven to perform in response to an obsession, or according to rules that must be applied rigidly.
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         2. The behaviors or mental acts are aimed at preventing or reducing anxiety or distress or preventing some dreaded event or situation; however, these behaviors or mental acts either are not connected in a realistic way with what they are designed to neutralize or prevent, or are clearly excessive.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Note: Young children may not be able to articulate the aims of these behaviors or mental acts.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         B. The obsessions or compulsions are time-consuming (eg, take more than 1 hour per day) or cause clinically significant distress or impairment in social, occupational, or other important areas of functioning.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         C. The obsessive-compulsive symptoms are not attributable to the physiological effects of a substance (eg, a drug of abuse, a medication) or another medical condition.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         D. The disturbance is not better explained by the symptoms of another mental disorder, for example:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Excessive worries, as in generalized anxiety disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Preoccupation with a defect in appearance, as in body dysmorphic disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Difficulty discarding or parting with possessions, as in hoarding disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hair pulling, as in trichotillomania (hair-pulling disorder)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Skin picking, as in excoriation (skin-picking) disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Stereotypies, as in stereotypic movement disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ritualized eating behavior, as in eating disorders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Preoccupation with substances or gambling, as in substance-related and addictive disorders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Preoccupation with having an illness, as in illness anxiety disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sexual urges or fantasies, as in paraphilic disorders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Impulses, as in disruptive, impulse-control, and conduct disorders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Guilty ruminations, as in major depressive disorder
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Thought insertion or delusional preoccupations, as in schizophrenia spectrum and other psychotic disorders
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Repetitive patterns of behavior, as in autism spectrum disorder
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H49086676">
         <span class="h3">
          Specifiers
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patient’s degree of insight into the illness
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         With good or fair insight – The individual recognizes that obsessive-compulsive disorder beliefs are definitely or probably not true or that they may or may not be true.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         With poor insight – The individual thinks obsessive-compulsive disorder beliefs are probably true.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         With absent insight/delusional beliefs – The individual is completely convinced that obsessive-compulsive disorder beliefs are true.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Presence or history of a tic disorder (see
         <a class="local">
          'Comorbidities'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H49086567">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of pediatric OCD can be challenging, particularly since comorbidity is the rule rather than the exception. (See
         <a class="local">
          'Comorbidities'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H476130758">
         <span class="h3">
          Normal development
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is imperative that normal developmental factors be ruled out. Certain repetitive, ritualistic behaviors can be seen at certain stages of the child’s development. As examples, children developing normally may be fascinated with symmetry or superstitions for periods of time.
        </p>
        <p class="headingAnchor" id="H476130771">
         <span class="h3">
          Early onset psychosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although patient insight into the unreal nature of his or her obsessions can distinguish OCD from psychotic disorders in adults, this is not necessarily true in children. The failure of treatment to respond to OCD treatment can be indicative of psychosis. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/90748.html" rel="external">
          "Obsessive-compulsive disorder in children and adolescents: Treatment overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H476130842">
         <span class="h3">
          Autism spectrum disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obsessions and compulsive behaviors can occur as part of autism spectrum disorders. While OCD patients often experience their symptoms as ego-dystonic, typically, the repetitive and stereotypic behaviors seen in autism spectrum disorders are not found to be excessive or problematic [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H476130889">
         <span class="h3">
          Tic disorder
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some tics can be similar to compulsions. A complex motor tic, such as repeating actions a specific number of times, can be indistinguishable from compulsions [
         <a href="#rid99">
          99,100
         </a>
         ]. To differentiate between the two, the clinician should explore whether there is simply an urge or uncomfortable feeling preceding the movement (as with tics), or if the action was preceded by a specific anxious thought, feeling of doom, or fear that something bad might happen which triggers the behavior, as with OCD.
        </p>
        <p class="headingAnchor" id="H476130861">
         <span class="h3">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other mental disorders have clinical features that may overlap with OCD on presentation, but can be distinguished from OCD based on other features of the disorder; these are described in Criteria D of DSM-5. (See
         <a class="local">
          'DSM-5 criteria'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H701833553">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/115511.html" rel="external">
          "Society guideline links: Obsessive-compulsive disorder and related disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H86799712">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obsessive-compulsive disorder (OCD) is a severe, prevalent and most often chronically debilitating disorder characterized by repetitive, ritualistic and distressing thoughts, ideas, and behaviors over which a person typically has very little if any control. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         OCD affects more than three million people in the United States. Estimates of the disorder’s United States lifetime prevalence in both pediatric and adult populations have ranged from 1 to 3 percent. More than half of pediatric patients with OCD have been found to have at least one comorbid psychiatric disorder, including tic disorder, attention deficit hyperactivity disorder, and mood and anxiety disorders. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Research suggests that multiple genetic risk factors lead to changes in cellular function or altered neurotransmitter signaling. These molecular and cellular changes perturb fronto-striatal-thalamic circuitry (FSTC), resulting in OCD. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The characteristic symptoms of obsessive-compulsive disorder are obsessions and/or compulsions that are time-consuming, cause clinically significant distress or impair functioning. Young children, compared to older children and adults, are less likely (and able to) describe obsessions in conjunction with observed compulsive actions, and less likely to have insight into the excessiveness or absurdity of their OCD symptoms. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Research suggests that approximately 50 percent of all cases of OCD have their onset in childhood or adolescence. The prognosis for pediatric OCD appears to be better than the prognosis for adult onset OCD. (See
         <a class="local">
          'Course'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It is particularly important that assessment for obsessions and compulsions evaluates children's lifetime, because OCD symptoms can wax and wane and change during the child’s developmental maturation. (See
         <a class="local">
          'Assessment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The differential diagnosis of childhood OCD includes normal childhood development, early onset psychosis, autism spectrum disorders, and tic disorder. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Pauls DL, Alsobrook JP 2nd, Goodman W, et al. A family study of obsessive-compulsive disorder. Am J Psychiatry 1995; 152:76.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janowitz D, Grabe HJ, Ruhrmann S, et al. Early onset of obsessive-compulsive disorder and associated comorbidity. Depress Anxiety 2009; 26:1012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weissman MM, Bland RC, Canino GJ, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry 1994; 55 Suppl:5.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valleni-Basile LA, Garrison CZ, Jackson KL, et al. Frequency of obsessive-compulsive disorder in a community sample of young adolescents. J Am Acad Child Adolesc Psychiatry 1994; 33:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart SE, Platko J, Fagerness J, et al. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry 2007; 64:209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenberg DR, Keshavan MS, Dick EL, et al. Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 1997; 21:1269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev 2001; 21:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heyman I, Fombonne E, Simmons H, et al. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Int Rev Psychiatry 2003; 15:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Douglass HM, Moffitt TE, Dar R, et al. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry 1995; 34:1424.
          </a>
         </li>
         <li class="breakAll">
          Flament M, Whitaker A, Rapoport J, et al. An epidemiological study of obsessive-compulsive disorder in adolescence. In: Obsessive Compulsive Disorder in Children and Adolescents, Rapoport J (Ed), American Psychiatric Press, Washington, DC 1989. p.253.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller DA, Biederman J, Griffin S, et al. Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 1996; 35:1637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller D, Biederman J, Jones J, et al. Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature. J Am Acad Child Adolesc Psychiatry 1998; 37:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller DA, Biederman J, Jones J, et al. Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry 1998; 5:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller D, Petty C, Vivas F, et al. Examining the relationship between obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis. Biol Psychiatry 2007; 61:316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller DA. The promise and challenge of obsessive-compulsive disorder research. Biol Psychiatry 2007; 61:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller D, Petty C, Vivas F, et al. Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis. Biol Psychiatry 2007; 61:1388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobin C, Blundell ML, Karayiorgou M. Phenotypic differences in early- and late-onset obsessive-compulsive disorder. Compr Psychiatry 2000; 41:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller D, Biederman J, Faraone SV, et al. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress Anxiety 2000; 11:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubenstein CS, Pigott TA, L'Heureux F, et al. A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder. J Clin Psychiatry 1992; 53:309.
          </a>
         </li>
         <li class="breakAll">
          Geller DA, Faro AL, Brown AR, Levy HC. Pediatric OCD: Developmental aspects and treatment considerations. In: Obsessive Compulsive Disorder: Current Science and Clinical Practice, Zohar J (Ed), Wiley-Blackwell, Hoboken, NJ 2012. p.160.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanna GL, Himle JA, Curtis GC, Gillespie BW. A family study of obsessive-compulsive disorder with pediatric probands. Am J Med Genet B Neuropsychiatr Genet 2005; 134B:13.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           do Rosario-Campos MC, Leckman JF, Curi M, et al. A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 136B:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158:1568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 1999; 88:38.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanna GL, Fingerlin TE, Himle JA, Boehnke M. Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Hum Hered 2005; 60:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nestadt G, Lan T, Samuels J, et al. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. Am J Hum Genet 2000; 67:1611.
          </a>
         </li>
         <li class="breakAll">
          Nicolini H, Hanna G, Baxter L, et al. Segregation analysis of obsessive compulsive and associated disorders: preliminary results. Ursus Medicus 1991; 1:25.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hanna GL, Veenstra-VanderWeele J, Cox NJ, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 2002; 114:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Willour VL, Yao Shugart Y, Samuels J, et al. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet 2004; 75:508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arnold PD, Sicard T, Burroughs E, et al. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006; 63:769.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dickel DE, Veenstra-VanderWeele J, Cox NJ, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 2006; 63:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baxter LR Jr, Schwartz JM, Bergman KS, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry 1997; 154:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodríguez N, Morer A, González-Navarro EA, et al. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J Neuroinflammation 2017; 14:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Çolak Sivri R, Bilgiç A, Kılınç İ. Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 2018; 27:977.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cosco TD, Pillinger T, Emam H, et al. Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis. Mol Neurobiol 2019; 56:4751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wohleb ES, McKim DB, Sheridan JF, Godbout JP. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci 2014; 8:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunn AJ. Effects of cytokines and infections on brain neurochemistry. Clin Neurosci Res 2006; 6:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lensi P, Cassano GB, Correddu G, et al. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry 1996; 169:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mathews CA, Bimson B, Lowe TL, et al. Association between maternal smoking and increased symptom severity in Tourette's syndrome. Am J Psychiatry 2006; 163:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santangelo SL, Pauls DL, Goldstein JM, et al. Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder? J Am Acad Child Adolesc Psychiatry 1994; 33:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller DA, Wieland N, Carey K, et al. Perinatal factors affecting expression of obsessive compulsive disorder in children and adolescents. J Child Adolesc Psychopharmacol 2008; 18:373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luxenberg JS, Swedo SE, Flament MF, et al. Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry 1988; 145:1089.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szeszko PR, MacMillan S, McMeniman M, et al. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder. Am J Psychiatry 2004; 161:1049.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenberg DR, Keshavan MS. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder. Biol Psychiatry 1998; 43:623.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szeszko PR, Christian C, Macmaster F, et al. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 2008; 165:1299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilbert AR, Moore GJ, Keshavan MS, et al. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 2000; 57:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JJ, Lee MC, Kim J, et al. Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images. Br J Psychiatry 2001; 179:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macmaster F, Vora A, Easter P, et al. Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder. Psychiatry Res 2010; 181:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Altemus M, Pigott T, Kalogeras KT, et al. Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swedo SE, Leonard HL, Kruesi MJ, et al. Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Catapano F, Monteleone P, Fuschino A, et al. Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder. Psychiatry Res 1992; 44:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Monteleone P, Catapano F, Tortorella A, Maj M. Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect. Neuropsychobiology 1997; 36:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leckman JF, Goodman WK, North WG, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls. Arch Gen Psychiatry 1994; 51:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacMaster FP, Russell A, Mirza Y, et al. Pituitary volume in pediatric obsessive-compulsive disorder. Biol Psychiatry 2006; 59:252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zarei M, Mataix-Cols D, Heyman I, et al. Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder. Biol Psychiatry 2011; 70:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gruner P, Vo A, Ikuta T, et al. White matter abnormalities in pediatric obsessive-compulsive disorder. Neuropsychopharmacology 2012; 37:2730.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzgerald KD, Liu Y, Reamer EN, et al. Atypical frontal-striatal-thalamic circuit white matter development in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2014; 53:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rauch SL, Jenike MA, Alpert NM, et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51:62.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998; :26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baxter LR Jr, Phelps ME, Mazziotta JC, et al. Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987; 44:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baxter LR Jr, Schwartz JM, Mazziotta JC, et al. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry 1988; 145:1560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nordahl TE, Benkelfat C, Semple WE, et al. Cerebral glucose metabolic rates in obsessive compulsive disorder. Neuropsychopharmacology 1989; 2:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzgerald KD, Welsh RC, Stern ER, et al. Developmental alterations of frontal-striatal-thalamic connectivity in obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2011; 50:938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diwadkar VA, Burgess A, Hong E, et al. Dysfunctional Activation and Brain Network Profiles in Youth with Obsessive-Compulsive Disorder: A Focus on the Dorsal Anterior Cingulate during Working Memory. Front Hum Neurosci 2015; 9:149.
          </a>
         </li>
         <li class="breakAll">
          Abudy A, Juven-Wetzler A, Sonnino R, Zohar J. Serotonin and beyond: a neurotransmitter perspective of OCD. In: Obsessive Compulsive Disorder: Current Science and Clinical Practice, Zohar J (Ed), Wiley-Blackwell, Hoboken, NJ 2012. p.220.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Russell A, Cortese B, Lorch E, et al. Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 2003; 13 Suppl 1:S31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenberg DR, MacMaster FP, Keshavan MS, et al. Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. J Am Acad Child Adolesc Psychiatry 2000; 39:1096.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benazon NR, Moore GJ, Rosenberg DR. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adolesc Psychiatry 2003; 42:1279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mirza Y, O'Neill J, Smith EA, et al. Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls. J Child Neurol 2006; 21:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bozkurt A, Zilles K, Schleicher A, et al. Distributions of transmitter receptors in the macaque cingulate cortex. Neuroimage 2005; 25:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toyoda H, Zhao MG, Zhuo M. Roles of NMDA receptor NR2A and NR2B subtypes for long-term depression in the anterior cingulate cortex. Eur J Neurosci 2005; 22:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenberg DR, Mirza Y, Russell A, et al. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 2004; 43:1146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yücel M, Wood SJ, Wellard RM, et al. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust N Z J Psychiatry 2008; 42:467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fitzgerald KD, Moore GJ, Paulson LA, et al. Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder. Biol Psychiatry 2000; 47:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2012; 51:98.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Keeley ML, Storch EA, Dhungana P, Geffken GR. Pediatric obsessive-compulsive disorder: a guide to assessment and treatment. Issues Ment Health Nurs 2007; 28:555.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan SW, Harmer CJ, Goodwin GM, Norbury R. Risk for depression is associated with neural biases in emotional categorisation. Neuropsychologia 2008; 46:2896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geller DA, Biederman J, Faraone S, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis 2001; 189:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Selles RR, Storch EA, Lewin AB. Variations in symptom prevalence and clinical correlates in younger versus older youth with obsessive-compulsive disorder. Child Psychiatry Hum Dev 2014; 45:666.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 2004; 110:4.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Atmaca M, Onalan E, Yildirim H, et al. The association of myelin oligodendrocyte glycoprotein gene and white matter volume in obsessive-compulsive disorder. J Affect Disord 2010; 124:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart SE, Stack DE, Tsilker S, et al. Long-term outcome following Intensive Residential Treatment of Obsessive-Compulsive Disorder. J Psychiatr Res 2009; 43:1118.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pittenger C, Krystal JH, Coric V. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 2006; 3:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benazon NR, Ager J, Rosenberg DR. Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial. Behav Res Ther 2002; 40:529.
          </a>
         </li>
         <li class="breakAll">
          Goodman W. The Course of Obsessive-Compulsive Disorder (OCD). Psych Central. http://psychcentral.com/lib/the-course-of-obsessive-compulsive-disorder-ocd/00079 (Accessed on August 26, 2014).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollingsworth CE, Tanguay PE, Grossman L, Pabst P. Long-term outcome of obsessive-compulsive disorder in childhood. J Am Acad Child Psychiatry 1980; 19:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scahill L, Riddle MA, McSwiggin-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36:844.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foa EB, Coles M, Huppert JD, et al. Development and validation of a child version of the obsessive compulsive inventory. Behav Ther 2010; 41:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abramovitch A, Abramowitz JS, McKay D, et al. The OCI-CV-R: A Revision of the Obsessive-Compulsive Inventory - Child Version. J Anxiety Disord 2022; 86:102532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson EC, Hanna GL, Hudziak JJ, et al. Obsessive-compulsive scale of the child behavior checklist: specificity, sensitivity, and predictive power. Pediatrics 2001; 108:E14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chorpita BF, Yim L, Moffitt C, et al. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther 2000; 38:835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bennett SD, Coughtrey AE, Shafran R, Heyman I. Measurement Issues: The measurement of obsessive compulsive disorder in children and young people in clinical practice. Child Adolesc Ment Health 2017; 22:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karver MS. Determinants of multiple informant agreement on child and adolescent behavior. J Abnorm Child Psychol 2006; 34:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rachman S, de Silva P. Abnormal and normal obsessions. Behav Res Ther 1978; 16:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veale D, Freeston M, Krebs G, et al. Risk assessment and management in obsessive–compulsive disorder. Adv Psychiatr Treat 2009; 15:332.
          </a>
         </li>
         <li class="breakAll">
          American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.
         </li>
         <li class="breakAll">
          Castellanos FX. Tic disorders and obsessive-compulsive disorder. In: Child Psychopharmacology, Walsh TB (Ed), American Psychiatric Association, Washington DC 1998.
         </li>
         <li class="breakAll">
          Towbin KE. Obsessive-compulsive symptoms in Tourette's syndrome. In: Tourette's Syndrome and Tic Disorders, Cohen DC, Bruun RD, Leckman JF (Eds), Wiley, New York 1988. p.137.
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 86436 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7802125" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A family study of obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19691024" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Early onset of obsessive-compulsive disorder and associated comorbidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15939837" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8077177" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8083134" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Frequency of obsessive-compulsive disorder in a community sample of young adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17283288" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9460091" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11148894" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12745330" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8543509" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8543509" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8973071" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9549963" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Is juvenile obsessive-compulsive disorder a developmental subtype of the disorder? A review of the pediatric literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9493948" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Obsessive-compulsive disorder in children and adolescents: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16950231" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Examining the relationship between obsessive-compulsive disorder and attention-deficit/hyperactivity disorder in children and adolescents: a familial risk analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17241827" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The promise and challenge of obsessive-compulsive disorder research.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17241617" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11011834" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Phenotypic differences in early- and late-onset obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10945136" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1517192" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1517192" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15635694" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : A family study of obsessive-compulsive disorder with pediatric probands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15892140" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : A family study of early-onset obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11578982" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : A review and meta-analysis of the genetic epidemiology of anxiety disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10050965" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Complex segregation analysis for obsessive compulsive disorder and related disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16088199" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11058433" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11058433" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12116192" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15272418" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16818866" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16818867" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1514872" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8988969" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29284508" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29302747" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30382535" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Immune Aberrations in Obsessive-Compulsive Disorder: a Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25653581" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18079991" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effects of cytokines and infections on brain neurochemistry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8818377" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16741208" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Association between maternal smoking and increased symptom severity in Tourette's syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8083136" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Tourette's syndrome: what are the influences of gender and comorbid obsessive-compulsive disorder?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18759647" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Perinatal factors affecting expression of obsessive compulsive disorder in children and adolescents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3414851" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15169693" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9582996" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18413702" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10807485" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11581113" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Grey matter abnormalities in obsessive-compulsive disorder: statistical parametric mapping of segmented magnetic resonance images.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20074911" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Orbital frontal cortex in treatment-naïve pediatric obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1370198" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Abnormalities in the regulation of vasopressin and corticotropin releasing factor secretion in obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1370197" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Cerebrospinal fluid neurochemistry in children and adolescents with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1289919" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Melatonin and cortisol secretion in patients with primary obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9211437" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Cortisol response to d-fenfluramine in patients with obsessive-compulsive disorder and in healthy subjects: evidence for a gender-related effect.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7524462" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16140279" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pituitary volume in pediatric obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21903200" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Changes in gray matter volume and white matter microstructure in adolescents with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22871914" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : White matter abnormalities in pediatric obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25440312" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Atypical frontal-striatal-thalamic circuit white matter development in pediatric obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8279930" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9829024" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3493749" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3264118" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2803479" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Cerebral glucose metabolic rates in obsessive compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21871375" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Developmental alterations of frontal-striatal-thalamic connectivity in obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25852529" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Dysfunctional Activation and Brain Network Profiles in Youth with Obsessive-Compulsive Disorder: A Focus on the Dorsal Anterior Cingulate during Working Memory.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25852529" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Dysfunctional Activation and Brain Network Profiles in Youth with Obsessive-Compulsive Disorder: A Focus on the Dorsal Anterior Cingulate during Working Memory.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12880498" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Localized functional neurochemical marker abnormalities in dorsolateral prefrontal cortex in pediatric obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10986805" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14566164" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16566872" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Increased medial thalamic creatine-phosphocreatine found by proton magnetic resonance spectroscopy in children with obsessive-compulsive disorder versus major depression and healthy controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15734357" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Distributions of transmitter receptors in the macaque cingulate cortex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16045501" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Roles of NMDA receptor NR2A and NR2B subtypes for long-term depression in the anterior cingulate cortex.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15322418" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18465373" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10682215" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22176943" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Practice parameter for the assessment and treatment of children and adolescents with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17613156" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Pediatric obsessive-compulsive disorder: a guide to assessment and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18601940" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Risk for depression is associated with neural biases in emotional categorisation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11504325" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24549726" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Variations in symptom prevalence and clinical correlates in younger versus older youth with obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15180774" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20452030" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : The association of myelin oligodendrocyte glycoprotein gene and white matter volume in obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19419736" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Long-term outcome following Intensive Residential Treatment of Obsessive-Compulsive Disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16490414" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12038645" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12038645" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Cognitive behavior therapy in treatment-naive children and adolescents with obsessive-compulsive disorder: an open trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7365165" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Long-term outcome of obsessive-compulsive disorder in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9183141" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20171333" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Development and validation of a child version of the obsessive compulsive inventory.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35091252" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : The OCI-CV-R: A Revision of the Obsessive-Compulsive Inventory - Child Version.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11433093" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Obsessive-compulsive scale of the child behavior checklist: specificity, sensitivity, and predictive power.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10937431" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32680318" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Measurement Issues: The measurement of obsessive compulsive disorder in children and young people in clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16514552" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Determinants of multiple informant agreement on child and adolescent behavior.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/718588" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Abnormal and normal obsessions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Risk assessment and management in obsessive–compulsive disorder
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
